Evidence map›Paper›PMID 39771513›Full record

ArticlePharmaceutics2024

Log BB Prediction Models Using TLC and HPLC Retention Values as Protein Affinity Data.

Karolina Wanat, Klaudia Michalak, Elżbieta Brzezińska

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karolina WanatDepartment of Analytical Chemistry, Faculty of Pharmacy, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0002-7764-4993
Klaudia MichalakDepartment of Analytical Chemistry, Faculty of Pharmacy, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0001-5001-7730
Elżbieta BrzezińskaDepartment of Analytical Chemistry, Faculty of Pharmacy, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0003-1135-7147

Funding

Medical University of Lodz 503/3-016-03/503-31-001
6 · The paper itself

Abstract

backgroundThe penetration of drugs through the blood-brain barrier is one of the key pharmacokinetic aspects of centrally acting active substances and other drugs in terms of the occurrence of side effects on the central nervous system. In our research, several regression models were constructed in order to observe the connections between the active pharmaceutical ingredients' properties and their bioavailability in the CNS, presented in the form of the log BB parameter, which refers to the drug concentration on both sides of the blood-brain barrier.

methodsPredictive models were created using the physicochemical properties of drugs, and multiple linear regression and a data mining method, i.e., MARSplines, were used to build them. Retention values from protein-affinity chromatography (TLC and HPLC) were introduced into the analyses. In both experiments, the stationary phases were modified with serum albumin, which enriched the obtained chromatographic data, and were then introduced into the models with good results.

resultsThe conducted analyses confirm that the variables that influence the log BB include high degree of lipophilicity, ionisation capacity and low capability of forming hydrogen bonds. However, the addition of chromatographic data improved the obtained regression results and increased the robustness of the models against an increased number of cases. The linear regression model with chromatographic parameters explains 85% of the log bb variability, whereas the MARSplines model explains 91%.

Indexed as

affinity chromatographychromatographic dataCNS penetrationlog BBregression modelsserum albumin

Identifiers

PMID39771513
PMCPMC11678311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.